TY - JOUR
T1 - MYH9-related disorders
T2 - Report on a patient of greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutation
AU - Economou, Marina
AU - Batzios, Spyros P.
AU - Pecci, Alessandro
AU - Printza, Nikoletta
AU - Savoia, Anna
AU - Barozzi, Serena
AU - Theodoridou, Stamatia
AU - Teli, Aikaterini
AU - Psillas, Georgios
AU - Zafeiriou, Dimitrios I.
PY - 2012/8
Y1 - 2012/8
N2 - Myosin heavy chain-9 (MYH9)-related disorders represent a heterogenous group of hereditary diseases caused by mutations in the gene encoding the heavy chain of nonmuscle myosin IIA. May-Hegglin anomaly and Fechtner, Sebastian, and Epstein syndromes are the four phenotypes of the disease, characterized by congenital macrothrombocytopenia and distinguished by different combinations of clinical signs that may include glomerulonephritis, sensorineural hearing loss, and presenile cataract. The spectrum of mutations responsible for the disease is wide and the existence of genotype-phenotype correlation remains a critical issue. We report the first case of an MYH9-RD in a patient of Greek origin presenting with macroscopic hematuria and presenile cataract caused by a p.R1165C mutation. The same mutation was present in the patient's father, who exhibited no extrahematological features of the disease. The p.R1165C mutation is one of the MYH9 alterations whose prognostic significance is still poorly defined. Thus, the patients described add to the limited existing data on the MYH9 mutations and their resultant phenotypes.
AB - Myosin heavy chain-9 (MYH9)-related disorders represent a heterogenous group of hereditary diseases caused by mutations in the gene encoding the heavy chain of nonmuscle myosin IIA. May-Hegglin anomaly and Fechtner, Sebastian, and Epstein syndromes are the four phenotypes of the disease, characterized by congenital macrothrombocytopenia and distinguished by different combinations of clinical signs that may include glomerulonephritis, sensorineural hearing loss, and presenile cataract. The spectrum of mutations responsible for the disease is wide and the existence of genotype-phenotype correlation remains a critical issue. We report the first case of an MYH9-RD in a patient of Greek origin presenting with macroscopic hematuria and presenile cataract caused by a p.R1165C mutation. The same mutation was present in the patient's father, who exhibited no extrahematological features of the disease. The p.R1165C mutation is one of the MYH9 alterations whose prognostic significance is still poorly defined. Thus, the patients described add to the limited existing data on the MYH9 mutations and their resultant phenotypes.
KW - Fechtner syndrome
KW - MYH9-related disorders
KW - nonmuscle myosin IIA
KW - p.R1165C mutation
UR - http://www.scopus.com/inward/record.url?scp=84864328013&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864328013&partnerID=8YFLogxK
U2 - 10.1097/MPH.0b013e318257a64b
DO - 10.1097/MPH.0b013e318257a64b
M3 - Article
C2 - 22627578
AN - SCOPUS:84864328013
SN - 1077-4114
VL - 34
SP - 412
EP - 415
JO - Journal of Pediatric Hematology/Oncology
JF - Journal of Pediatric Hematology/Oncology
IS - 6
ER -